Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

RFL

Rafael (RFL)

Rafael Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:RFL
일자시간출처헤드라인심볼기업
2021/10/0619:30PR Newswire (US)Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical OfficerAMEX:RFLRafael Holdings Inc
2021/09/1805:01PR Newswire (US)Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08AMEX:RFLRafael Holdings Inc
2021/08/2020:00PR Newswire (US)Rafael Holdings Announces $104.2 Million Private PlacementAMEX:RFLRafael Holdings Inc
2021/08/1723:11PR Newswire (US)Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics CompanyAMEX:RFLRafael Holdings Inc
2021/06/3021:00GlobeNewswire Inc.Rafael Pharmaceuticals to Present Pancreatic & Biliary Tract Cancer Data on CPI-613® (Devimistat) from its Multicenter, Rand...AMEX:RFLRafael Holdings Inc
2021/06/3000:00GlobeNewswire Inc.FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (Devimistat) for Treatment of Biliary CancerAMEX:RFLRafael Holdings Inc
2021/06/2401:39PR Newswire (US)Rafael Holdings and Rafael Pharmaceuticals Management Presented at the Raymond James 2021 Human Health Innovation Conference ...AMEX:RFLRafael Holdings Inc
2021/05/2622:00GlobeNewswire Inc.Rafael Pharmaceuticals to Present New Pancreatic Cancer and Biliary Tract Cancer Data featuring CPI-613® (Devimistat) at the...AMEX:RFLRafael Holdings Inc
2021/04/1706:00PR Newswire (US)Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08AMEX:RFLRafael Holdings Inc
2021/03/3022:00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Enrollment of 150 Patients in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) fo...AMEX:RFLRafael Holdings Inc
2021/01/2001:30GlobeNewswire Inc.Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor ConferenceAMEX:RFLRafael Holdings Inc
2021/01/1323:00GlobeNewswire Inc.Rafael Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare ConferenceAMEX:RFLRafael Holdings Inc
2020/12/2222:30PR Newswire (US)Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor P...AMEX:RFLRafael Holdings Inc
2020/12/1601:09GlobeNewswire Inc.UPDATE - Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Mye...AMEX:RFLRafael Holdings Inc
2020/12/1523:00GlobeNewswire Inc.Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leuk...AMEX:RFLRafael Holdings Inc
2020/12/0202:05GlobeNewswire Inc.Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimista...AMEX:RFLRafael Holdings Inc
2020/12/0123:00GlobeNewswire Inc.Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimista...AMEX:RFLRafael Holdings Inc
2020/11/1023:00GlobeNewswire Inc.Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Pancreatic CancerAMEX:RFLRafael Holdings Inc
2020/10/2922:30GlobeNewswire Inc.FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (devimistat) for Treatment of Soft Tissue SarcomaAMEX:RFLRafael Holdings Inc
2020/10/2722:00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Enrollment of 100th Patient in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) f...AMEX:RFLRafael Holdings Inc
2020/10/2022:00GlobeNewswire Inc.A New Phase 1 Study Began to Evaluate Rafael Pharmaceuticals’ Lead Compound CPI-613®️ (devimistat) for Patients With Pan...AMEX:RFLRafael Holdings Inc
2020/08/2421:30PR Newswire (US)Rafael Holdings to Present at LD Micro Investor ConferenceAMEX:RFLRafael Holdings Inc
2020/08/0622:00GlobeNewswire Inc.Rafael Pharmaceuticals Achieves Target Enrollment of 500 Patients in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ®️ (de...AMEX:RFLRafael Holdings Inc
2020/07/2122:00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Midpoint of Enrollment to First Interim Analysis in Pivotal Phase 3 Trial (ARMADA 2000) of CPI...AMEX:RFLRafael Holdings Inc
2020/06/1006:28PR Newswire (US)Rafael Holdings Reports Third Quarter Fiscal Year 2020 ResultsAMEX:RFLRafael Holdings Inc
2020/06/1006:25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RFLRafael Holdings Inc
2020/06/1006:17Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RFLRafael Holdings Inc
2020/05/2622:00GlobeNewswire Inc.Rafael Pharmaceuticals to Present Phase 1 Data on CPI-613® (Devimistat) in Patients with Locally Advanced or Metastatic Panc...AMEX:RFLRafael Holdings Inc
2020/05/0722:00GlobeNewswire Inc.Rafael Pharmaceuticals Announces In Vivo Study to Evaluate the Effects of CPI-613® (Devimistat) in Combination with Azacitid...AMEX:RFLRafael Holdings Inc
2020/05/0522:00GlobeNewswire Inc.Rafael Pharmaceuticals Enters into Research Collaboration with Roswell Park Comprehensive Cancer Center to Evaluate the Effec...AMEX:RFLRafael Holdings Inc
 검색 관련기사 보기:AMEX:RFL

최근 히스토리

Delayed Upgrade Clock